MENY

Gällande vårdprogram gallvägs- och gallblåsecancer

Fastställt av Regionala cancercentrum i samverkan 2017-01-16

20. Referenser

    1. Patel T. Cholangiocarcinoma--controversies and challenges. Nature reviews Gastroenterology & hepatology. 2011;8(4):189-200.
    2. Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nature reviews Gastroenterology & hepatology. 2011;8(9):512-22.
    3. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer science. 2010;101(3):579-85.
    4. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168-79.
    5. Bragazzi MC, Cardinale V, Carpino G, et al. Cholangiocarcinoma: Epidemiology and risk factors. Transl Gastrointest Cancer 2012;1:21-32.
    6. Komuta M, Govaere O, Vandecaveye V, Akiba J, Van Steenbergen W, Verslype C, et al. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology. 2012;55(6):1876-88.
    7. Ekbom A, Hsieh CC, Yuen J, Trichopoulos D, McLaughlin JK, Lan SJ, et al. Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet. 1993;342(8882):1262-5.
    8. Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S, et al. Epidemiology of biliary tract cancers: an update. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2009;20(1):146-59.
    9. Corwin MT, Siewert B, Sheiman RG, Kane RA. Incidentally detected gallbladder polyps: is follow-up necessary?--Long-term clinical and US analysis of 346 patients. Radiology. 2011;258(1):277-82.
    10. Shin SR, Lee JK, Lee KH, Lee KT, Rhee JC, Jang KT, et al. Can the growth rate of a gallbladder polyp predict a neoplastic polyp? Journal of clinical gastroenterology. 2009;43(9):865-8.
    11. Cairns V, Neal CP, Dennison AR, Garcea G. Risk and Cost-effectiveness of Surveillance Followed by Cholecystectomy for Gallbladder Polyps. Archives of surgery. 2012;147(12):1078-83.
    12. Lee KF, Wong J, Li JC, Lai PB. Polypoid lesions of the gallbladder. American journal of surgery. 2004;188(2):186-90.
    13. Park JY, Hong SP, Kim YJ, Kim HJ, Kim HM, Cho JH, et al. Long-term follow up of gallbladder polyps. Journal of gastroenterology and hepatology. 2009;24(2):219-22.
    14. Wiles R, Varadpande M, Muly S, Webb J. Growth rate and malignant potential of small gallbladder polyps--systematic review of evidence. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. 2014;12(4):221-6.
    15. Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology. 2011;54(5):1842-52.
    16. Stiehl A, Rudolph G, Kloters-Plachky P, Sauer P, Walker S. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. Journal of hepatology. 2002;36(2):151-6.
    17. Bjornsson E, Lindqvist-Ottosson J, Asztely M, Olsson R. Dominant strictures in patients with primary sclerosing cholangitis. The American journal of gastroenterology. 2004;99(3):502-8.
    18. Gotthardt DN, Rudolph G, Kloters-Plachky P, Kulaksiz H, Stiehl A. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointestinal endoscopy. 2010;71(3):527-34.
    19. Tischendorf JJ, Kruger M, Trautwein C, Duckstein N, Schneider A, Manns MP, et al. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy. 2006;38(7):665-9.
    20. Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology. 2008;48(4):1106-17.
    21. Alkhawaldeh K, Faltten S, Biersack HJ, Ezziddin S. The value of F-18 FDG PET in patients with primary sclerosing cholangitis and cholangiocarcinoma using visual and semiquantitative analysis. Clinical nuclear medicine. 2011;36(10):879-83.
    22. Sangfelt P, Sundin A, Wanders A, Rasmussen I, Karlson BM, Bergquist A, et al. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET. Journal of hepatology. 2014;61(6):1352-7.
    23. Bjornsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver. 1999;19(6):501-8.
    24. Buffet C, Fourre C, Altman C, Prat F, Fritsch J, Choury A, et al. Bile levels of carcino-embryonic antigen in patients with hepatopancreatobiliary disease. European journal of gastroenterology & hepatology. 1996;8(2):131-4.
    25. Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology. 2000;31(1):7-11.
    26. Lindberg B, Arnelo U, Bergquist A, Thorne A, Hjerpe A, Granqvist S, et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy. 2002;34(11):909-16.
    27. Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE, Jr. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clinic proceedings. 1993;68(9):874-9.
    28. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology. 1995;108(3):865-9.
    29. Siqueira E, Schoen RE, Silverman W, Martin J, Rabinovitz M, Weissfeld JL, et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointestinal endoscopy. 2002;56(1):40-7.
    30. Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. Journal of hepatology. 2006;45(4):568-74.
    31. Soares KC, Arnaoutakis DJ, Kamel I, Rastegar N, Anders R, Maithel S, et al. Choledochal cysts: presentation, clinical differentiation, and management. Journal of the American College of Surgeons. 2014;219(6):1167-80.
    32. Huang CS, Huang CC, Chen DF. Choledochal cysts: differences between pediatric and adult patients. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2010;14(7):1105-10.
    33. Tsai MS, Lin WH, Hsu WM, Lai HS, Lee PH, Chen WJ. Clinicopathological feature and surgical outcome of choledochal cyst in different age groups: the implication of surgical timing. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2008;12(12):2191-5.
    34. Jan YY, Chen HM, Chen MF. Malignancy in choledochal cysts. Hepato-gastroenterology. 2002;49(43):100-3.
    35. Song HK, Kim MH, Myung SJ, Lee SK, Kim HJ, Yoo KS, et al. Choledochal cyst associated the with anomalous union of pancreaticobiliary duct (AUPBD) has a more grave clinical course than choledochal cyst alone. The Korean journal of internal medicine. 1999;14(2):1-8.
    36. Stain SC, Guthrie CR, Yellin AE, Donovan AJ. Choledochal cyst in the adult. Annals of surgery. 1995;222(2):128-33.
    37. Bismuth H, Krissat J. Choledochal cystic malignancies. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 1999;10 Suppl 4:94-8.
    38. Fumino S, Higuchi K, Aoi S, Furukawa T, Kimura O, Tajiri T. Clinical analysis of liver fibrosis in choledochal cyst. Pediatric surgery international. 2013;29(11):1097-102.
    39. Suita S, Shono K, Kinugasa Y, Kubota M, Matsuo S. Influence of age on the presentation and outcome of choledochal cyst. Journal of pediatric surgery. 1999;34(12):1765-8.
    40. Narayanan SK, Chen Y, Narasimhan KL, Cohen RC. Hepaticoduodenostomy versus hepaticojejunostomy after resection of choledochal cyst: a systematic review and meta-analysis. Journal of pediatric surgery. 2013;48(11):2336-42.
    41. Mabrut JY, Kianmanesh R, Nuzzo G, Castaing D, Boudjema K, Letoublon C, et al. Surgical management of congenital intrahepatic bile duct dilatation, Caroli's disease and syndrome: long-term results of the French Association of Surgery Multicenter Study. Annals of surgery. 2013;258(5):713-21; discussion 21.
    42. Ono S, Fumino S, Shimadera S, Iwai N. Long-term outcomes after hepaticojejunostomy for choledochal cyst: a 10- to 27-year follow-up. Journal of pediatric surgery. 2010;45(2):376-8.
    43. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. Journal of hepato-biliary-pancreatic surgery. 2003;10(4):288-91.
    44. Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, et al. Intrahepatic cholangiocarcinoma: new insights in pathology. Seminars in liver disease. 2011;31(1):49-60.
    45. Choi BI, Lee JM, Han JK. Imaging of intrahepatic and hilar cholangiocarcinoma. Abdominal imaging. 2004;29(5):548-57.
    46. Asayama Y, Yoshimitsu K, Irie H, Tajima T, Nishie A, Hirakawa M, et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology. 2006;238(1):150-5.
    47. Han JK, Choi BI, Kim AY, An SK, Lee JW, Kim TK, et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics : a review publication of the Radiological Society of North America, Inc. 2002;22(1):173-87.
    48. Kim SA, Lee JM, Lee KB, Kim SH, Yoon SH, Han JK, et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology. 2011;260(1):148-57.
    49. Kim SJ, Lee JM, Han JK, Kim KH, Lee JY, Choi BI. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR American journal of roentgenology. 2007;189(6):1428-34.
    50. Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, et al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology. 2009;50(3):791-8.
    51. Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2009;29(3):683-700.
    52. Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR American journal of roentgenology. 2003;181(3):819-27.
    53. Kim NR, Lee JM, Kim SH, An SK, Han CJ, Choi SH, et al. Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes. Clinical imaging. 2008;32(2):114-20.
    54. Lee JW, Han JK, Kim TK, Kim YH, Choi BI, Han MC, et al. CT features of intraductal intrahepatic cholangiocarcinoma. AJR American journal of roentgenology. 2000;175(3):721-5.
    55. Kim JE, Lee JM, Kim SH, Baek JH, Moon SK, Yu IS, et al. Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. Radiology. 2010;257(2):364-72.
    56. Kim H, Lim JH, Jang KT, Kim MJ, Lee J, Lee JY, et al. Morphology of intraductal papillary neoplasm of the bile ducts: radiologic-pathologic correlation. Abdominal imaging. 2011;36(4):438-46.
    57. Lim JH, Kim YI, Park CK. Intraductal mucosal-spreading mucin-producing peripheral cholangiocarcinoma of the liver. Abdominal imaging. 2000;25(1):89-92.
    58. Lim JH, Yoon KH, Kim SH, Kim HY, Lim HK, Song SY, et al. Intraductal papillary mucinous tumor of the bile ducts. Radiographics : a review publication of the Radiological Society of North America, Inc. 2004;24(1):53-66; discussion -7.
    59. Ayuso JR, Pages M, Darnell A. Imaging bile duct tumors: staging. Abdominal imaging. 2013;38(5):1071-81.
    60. Kang Y, Lee JM, Kim SH, Han JK, Choi BI. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology. 2012;264(3):751-60.
    61. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC medical research methodology. 2003;3:25.
    62. Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. Journal of hepatology. 2014;60(6):1268-89.
    63. Li J, Kuehl H, Grabellus F, Muller SP, Radunz S, Antoch G, et al. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. Journal of surgical oncology. 2008;98(6):438-43.
    64. Fritscher-Ravens A, Bohuslavizki KH, Broering DC, Jenicke L, Schafer H, Buchert R, et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nuclear medicine communications. 2001;22(12):1277-85.
    65. Reinhardt MJ, Strunk H, Gerhardt T, Roedel R, Jaeger U, Bucerius J, et al. Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2005;46(7):1158-63.
    66. Joo I, Lee JM. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection. Abdominal imaging. 2013;38(6):1334-50.
    67. Yachimski P, Pratt DS. Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients. Journal of clinical gastroenterology. 2008;42(2):178-90.
    68. Morris-Stiff G, Bhati C, Olliff S, Hubscher S, Gunson B, Mayer D, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience. Digestive surgery. 2008;25(2):126-32.
    69. Vitellas KM, Keogan MT, Freed KS, Enns RA, Spritzer CE, Baillie JM, et al. Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. Radiographics : a review publication of the Radiological Society of North America, Inc. 2000;20(4):959-75; quiz 1108-9, 12.
    70. Elsayes KM, Oliveira EP, Narra VR, Abou El Abbass HA, Ahmed MI, Tongdee R, et al. MR and MRCP in the evaluation of primary sclerosing cholangitis: current applications and imaging findings. Journal of computer assisted tomography. 2006;30(3):398-404.
    71. Eun HW, Kim JH, Hong SS, Kim YJ. Malignant versus benign hepatic masses in patients with recurrent pyogenic cholangitis: MR differential diagnosis. Abdominal imaging. 2012;37(5):767-74.
    72. Levy AD, Murakata LA, Rohrmann CA, Jr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2001;21(2):295-314; questionnaire, 549-55.
    73. Furlan A, Ferris JV, Hosseinzadeh K, Borhani AA. Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options. AJR American journal of roentgenology. 2008;191(5):1440-7.
    74. Pandey M, Sood BP, Shukla RC, Aryya NC, Singh S, Shukla VK. Carcinoma of the gallbladder: role of sonography in diagnosis and staging. Journal of clinical ultrasound : JCU. 2000;28(5):227-32.
    75. Yoshimitsu K, Honda H, Shinozaki K, Aibe H, Kuroiwa T, Irie H, et al. Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection. AJR American journal of roentgenology. 2002;179(2):423-8.
    76. Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D'Angelica M, Fong Y, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. Journal of the American College of Surgeons. 2008;206(1):57-65.
    77. Rodriguez-Fernandez A, Gomez-Rio M, Medina-Benitez A, Moral JV, Ramos-Font C, Ramia-Angel JM, et al. Application of modern imaging methods in diagnosis of gallbladder cancer. Journal of surgical oncology. 2006;93(8):650-64.
    78. Trikudanathan G, Navaneethan U, Njei B, Vargo JJ, Parsi MA. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointestinal endoscopy. 2014;79(5):783-9.
    79. de Bellis M, Fogel EL, Sherman S, Watkins JL, Chappo J, Younger C, et al. Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointestinal endoscopy. 2003;58(2):176-82.
    80. Pitman MB, Layfield LJ. Guidelines for pancreaticobiliary cytology from the Papanicolaou Society of Cytopathology: A review. Cancer cytopathology. 2014;122(6):399-411.
    81. Pitman MB, Centeno BA, Ali SZ, Genevay M, Stelow E, Mino-Kenudson M, et al. Standardized terminology and nomenclature for pancreatobiliary cytology: the Papanicolaou Society of Cytopathology guidelines. Diagnostic cytopathology. 2014;42(4):338-50.
    82. Kurtycz DF, Field A, Tabatabai L, Michaels C, Young N, Schmidt CM, et al. Post-brushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: The Papanicolaou Society of Cytopathology Guidelines. CytoJournal. 2014;11(Suppl 1):5.
    83. Adler D, Schmidt CM, Al-Haddad M, Barthel JS, Ljung BM, Merchant NB, et al. Clinical evaluation, imaging studies, indications for cytologic study and preprocedural requirements for duct brushing studies and pancreatic fine-needle aspiration: The Papanicolaou Society of Cytopathology Guidelines. CytoJournal. 2014;11(Suppl 1):1.
    84. Layfield LJ, Ehya H, Filie AC, Hruban RH, Jhala N, Joseph L, et al. Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: The Papanicolaou Society of Cytopathology Guidelines. CytoJournal. 2014;11(Suppl 1):4.
    85. Layfield LJ, Dodd L, Factor R, Schmidt RL. Malignancy risk associated with diagnostic categories defined by the Papanicolaou Society of Cytopathology pancreaticobiliary guidelines. Cancer cytopathology. 2014;122(6):420-7.
    86. Brugge W, Dewitt J, Klapman JB, Ashfaq R, Shidham V, Chhieng D, et al. Techniques for cytologic sampling of pancreatic and bile duct lesions. Diagnostic cytopathology. 2014;42(4):333-7.
    87. Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, Imrie CW, et al. Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. Journal of clinical pathology. 2001;54(6):449-55.
    88. Selvaggi SM. Biliary brushing cytology. Cytopathology : official journal of the British Society for Clinical Cytology. 2004;15(2):74-9.
    89. Boldorini R, Paganotti A, Andorno S, Orlando S, Mercalli F, Orsello M, et al. A multistep cytological approach for patients with jaundice and biliary strictures of indeterminate origin. Journal of clinical pathology. 2015;68(4):283-7.
    90. Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61(12):1657-69.
    91. Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA, et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. The Journal of molecular diagnostics : JMD. 2000;2(3):116-23.
    92. Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. The Journal of urology. 2000;164(5):1768-75.
    93. Gonda TA, Glick MP, Sethi A, Poneros JM, Palmas W, Iqbal S, et al. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures. Gastrointestinal endoscopy. 2012;75(1):74-9.
    94. Moon JH, Choi HJ. The role of direct peroral cholangioscopy using an ultraslim endoscope for biliary lesions: indications, limitations, and complications. Clinical endoscopy. 2013;46(5):537-9.
    95. Moon JH, Terheggen G, Choi HJ, Neuhaus H. Peroral cholangioscopy: diagnostic and therapeutic applications. Gastroenterology. 2013;144(2):276-82.
    96. Monga A, Ramchandani M, Reddy DN. Per-oral cholangioscopy. Journal of interventional gastroenterology. 2011;1(2):70-7.
    97. Kawakami H, Kuwatani M, Etoh K, Haba S, Yamato H, Shinada K, et al. Endoscopic retrograde cholangiography versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer. Endoscopy. 2009;41(11):959-64.
    98. Wani S, Shah RJ. Probe-based confocal laser endomicroscopy for the diagnosis of indeterminate biliary strictures. Current opinion in gastroenterology. 2013;29(3):319-23.
    99. Itoi T, Kamisawa T, Igarashi Y, Kawakami H, Yasuda I, Itokawa F, et al. The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. Journal of gastroenterology. 2013;48(4):504-14.
    100. Sugiyama H, Tsuyuguchi T, Sakai Y, Ohtsuka M, Miyazaki M, Yokosuka O. Potential role of peroral cholangioscopy for preoperative diagnosis of cholangiocarcinoma. Surgical laparoscopy, endoscopy & percutaneous techniques. 2012;22(6):532-6.
    101. Paik WH, Park YS, Hwang JH, Lee SH, Yoon CJ, Kang SG, et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointestinal endoscopy. 2009;69(1):55-62.
    102. Kawakami H, Kuwatani M, Onodera M, Haba S, Eto K, Ehira N, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. Journal of gastroenterology. 2011;46(2):242-8.
    103. Kloek JJ, van der Gaag NA, Aziz Y, Rauws EA, van Delden OM, Lameris JS, et al. Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2010;14(1):119-25.
    104. Ratti F, Cipriani F, Ferla F, Catena M, Paganelli M, Aldrighetti LA. Hilar cholangiocarcinoma: preoperative liver optimization with multidisciplinary approach. Toward a better outcome. World journal of surgery. 2013;37(6):1388-96.
    105. Speer AG, Cotton PB, Russell RC, Mason RR, Hatfield AR, Leung JW, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987;2(8550):57-62.
    106. Born P, Rosch T, Triptrap A, Frimberger E, Allescher HD, Ott R, et al. Long-term results of percutaneous transhepatic biliary drainage for benign and malignant bile duct strictures. Scandinavian journal of gastroenterology. 1998;33(5):544-9.
    107. Fang Y, Gurusamy KS, Wang Q, Davidson BR, Lin H, Xie X, et al. Pre-operative biliary drainage for obstructive jaundice. The Cochrane database of systematic reviews. 2012;9:CD005444.
    108. Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Annals of surgery. 2002;236(1):17-27.
    109. Farges O, Regimbeau JM, Fuks D, Le Treut YP, Cherqui D, Bachellier P, et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. The British journal of surgery. 2013;100(2):274-83.
    110. Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, Khor CJ, Ponnudurai R, Moon JH, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. Journal of gastroenterology and hepatology. 2013;28(4):593-607.
    111. Nagino M, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Kondo S, et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. Journal of hepato-biliary-pancreatic surgery. 2008;15(1):25-30.
    112. Yu FX, Ji SQ, Su LF, Zhang SC, Zhang QY. Effectiveness and safety of preoperative percutaneous transhepatic cholangiodrainage with bile re-infusion in patients with hilar cholangiocarcinoma: a retrospective controlled study. The American journal of the medical sciences. 2013;346(5):353-7.
    113. Gerhards MF, Gonzalez DG, ten Hoopen-Neumann H, van Gulik TM, de Wit LT, Gouma DJ. Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2000;26(5):480-5.
    114. Kang MJ, Choi YS, Jang JY, Han IW, Kim SW. Catheter tract recurrence after percutaneous biliary drainage for hilar cholangiocarcinoma. World journal of surgery. 2013;37(2):437-42.
    115. Takahashi Y, Nagino M, Nishio H, Ebata T, Igami T, Nimura Y. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. The British journal of surgery. 2010;97(12):1860-6.
    116. Rystedt J, Montgomery A, Persson G. Completeness and correctness of cholecystectomy data in a national register--GallRiks. Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society. 2014;103(4):237-44.
    117. Enochsson L, Thulin A, Osterberg J, Sandblom G, Persson G. The Swedish Registry of Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks): A nationwide registry for quality assurance of gallstone surgery. JAMA surgery. 2013;148(5):471-8.
    118. Prachayakul V, Chaisayan S, Aswakul P, Deesomsak M. Clinical characteristics and treatment outcomes of patients with unresectable cholangiocarcinoma in Thailand: are there differences dependent on stent type? Asian Pacific journal of cancer prevention : APJCP. 2013;14(1):529-32.
    119. Raju RP, Jaganmohan SR, Ross WA, Davila ML, Javle M, Raju GS, et al. Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents. Digestive diseases and sciences. 2011;56(5):1557-64.
    120. Sangchan A, Kongkasame W, Pugkhem A, Jenwitheesuk K, Mairiang P. Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointestinal endoscopy. 2012;76(1):93-9.
    121. Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointestinal endoscopy. 2006;63(7):986-95.
    122. Kullman E, Frozanpor F, Soderlund C, Linder S, Sandstrom P, Lindhoff-Larsson A, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointestinal endoscopy. 2010;72(5):915-23.
    123. Dahlstrand U, Sandblom G, Eriksson LG, Nyman R, Rasmussen IC. Primary patency of percutaneously inserted self-expanding metallic stents in patients with malignant biliary obstruction. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2009;11(4):358-63.
    124. Lawson AJ, Beningfield SJ, Krige JE, Rischbieter P, Burmeister S. Percutaneous transhepatic self-expanding metal stents for palliation of malignant biliary obstruction. South African journal of surgery Suid-Afrikaanse tydskrif vir chirurgie. 2012;50(3):54, 6, 8 passim.
    125. De Palma GD, Galloro G, Siciliano S, Iovino P, Catanzano C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointestinal endoscopy. 2001;53(6):547-53.
    126. Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointestinal endoscopy. 1998;47(5):354-62.
    127. Hintze RE, Abou-Rebyeh H, Adler A, Veltzke-Schlieker W, Felix R, Wiedenmann B. Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointestinal endoscopy. 2001;53(1):40-6.
    128. Harewood GC, Baron TH. Cost analysis of magnetic resonance cholangiography in the management of inoperable hilar biliary obstruction. The American journal of gastroenterology. 2002;97(5):1152-8.
    129. Cholangiocarcinoma: A Nursing Perspective, Pack D. A, O’Connor K, O’Hagan K, Clinical Journal of Oncology Nursing (2001) VOLUME 5, NUMBER 4 
    130. Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2007;11(5):671-81.
    131. Juntermanns B, Radunz S, Heuer M, Hertel S, Reis H, Neuhaus JP, et al. Tumor markers as a diagnostic key for hilar cholangiocarcinoma. European journal of medical research. 2010;15(8):357-61.
    132. Zervos EE, Osborne D, Goldin SB, Villadolid DV, Thometz DP, Durkin A, et al. Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. American journal of surgery. 2005;190(5):810-5.
    133. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumor. Wiley-Blackwell; 2009. p. 256.
    134. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group., (2011.
    135. de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(23):3140-5.
    136. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Annals of surgery. 1992;215(1):31-8.
    137. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surgery, gynecology & obstetrics. 1975;140(2):170-8.
    138. Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Annals of surgery. 2005;241(5):693-9; discussion 9-702.
    139. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Annals of surgery. 2001;234(4):507-17; discussion 17-9.
    140. Deoliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, et al. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011;53(4):1363-71.
    141. de Jong MC, Hong SM, Augustine MM, Goggins MG, Wolfgang CL, Hirose K, et al. Hilar cholangiocarcinoma: tumor depth as a predictor of outcome. Archives of surgery. 2011;146(6):697-703.
    142. Koh CY, Demirjian AN, Chen WP, McLaren CE, Imagawa DK. Validation of revised American Joint Committee on Cancer staging for gallbladder cancer based on a single institution experience. The American surgeon. 2013;79(10):1045-9.
    143. Kwon YJ, Lee KG. Is T-stage the only significant factor determining the extent of surgery for gallbladder cancer? Hepato-gastroenterology. 2014;61(130):304-6.
    144. Oh TG, Chung MJ, Bang S, Park SW, Chung JB, Song SY, et al. Comparison of the sixth and seventh editions of the AJCC TNM classification for gallbladder cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2013;17(5):925-30.
    145. Bosman FT, Carneiro F, Hruban RH, Theise ND (eds). WHO Classification of Tumours of the Digestive System (4th edition).  IARC Lyon,  2010.
    146. Edge SB, Byrd DR, Comptom CC, Fritz AG, Grenne FL, Trotti A (eds). AJCC Cancer Staging Manual (7th edition). Springer, 2010.
    147. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene. 2006;25(27):3818-22.
    148. Komuta M, Spee B, Vander Borght S, De Vos R, Verslype C, Aerts R, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 2008;47(5):1544-56.
    149. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World journal of surgery. 2009;33(6):1247-54.
    150. Nakanuma Y, Sasaki M, Ikeda H, Sato Y, Zen Y, Kosaka K, et al. Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis. Hepatology research : the official journal of the Japan Society of Hepatology. 2008;38(4):325-34.
    151. Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Current opinion in gastroenterology. 2010;26(3):269-73.
    152. Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. The American journal of surgical pathology. 2000;24(6):870-6.
    153. Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer science. 2004;95(7):592-5.
    154. Cardinale V, Semeraro R, Torrice A, Gatto M, Napoli C, Bragazzi MC, et al. Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World journal of gastrointestinal oncology. 2010;2(11):407-16.
    155. Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Annals of surgery. 1998;227(3):405-11.
    156. Todoroki T, Okamura T, Fukao K, Nishimura A, Otsu H, Sato H, et al. Gross appearance of carcinoma of the main hepatic duct and its prognosis. Surgery, gynecology & obstetrics. 1980;150(1):33-40.
    157. Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Annals of surgery. 2005;241(5):703-12; discussion 12-4.
    158. Chang YR, Lee KB, Jang JY, Lim CS, Kang MJ, Kwon W, et al. Analysis of microscopic tumor spread patterns according to gross morphologies and suggestions for optimal resection margins in bile duct cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2014;18(6):1146-54.
    159. Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Annals of surgery. 2003;237(2):201-7.
    160. Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broome U, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scandinavian journal of gastroenterology. 2002;37(10):1205-11.
    161. Abbas G, Lindor KD. Cholangiocarcinoma in primary sclerosing cholangitis. Journal of gastrointestinal cancer. 2009;40(1-2):19-25.
    162. Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). Journal of surgical oncology. 2008;98(7):485-9.
    163. Albores-Saavedra J, Keenportz B, Bejarano PA, Alexander AA, Henson DE. Adenomyomatous hyperplasia of the gallbladder with perineural invasion: revisited. The American journal of surgical pathology. 2007;31(10):1598-604.
    164. Jun SR, Lee JM, Han JK, Choi BI. High-grade neuroendocrine carcinomas of the gallbladder and bile duct: Report of four cases with pathological correlation. Journal of computer assisted tomography. 2006;30(4):604-9.
    165. Albores-Saavedra J, Batich K, Hossain S, Henson DE, Schwartz AM. Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program. Annals of diagnostic pathology. 2009;13(6):378-83.
    166. Sasaki E, Nagino M, Ebata T, Oda K, Arai T, Nishio H, et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Annals of surgery. 2006;244(1):99-105.
    167. Yamaguchi R, Nagino M, Oda K, Kamiya J, Uesaka K, Nimura Y. Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. The British journal of surgery. 2002;89(9):1130-6.
    168. Donohue JH, Nagorney DM, Grant CS et al. An aggressive surgical approach leads to improved survival  in patients with gall bladder cancer. Does radical resection improve outcome? Arch Surg 2005; 125: 237-241.
    169. Miller G, Jarnagin WR. Gallbladder carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2008;34(3):306-12.
    170. Aramaki M, Matsumoto T, Shibata K, Himeno Y, Yada K, Hirano S, et al. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma. Hepato-gastroenterology. 2004;51(60):1609-11.
    171. Chijiiwa K, Yamaguchi K, Tanaka M. Clinicopathologic differences between long-term and short-term postoperative survivors with advanced gallbladder carcinoma. World journal of surgery. 1997;21(1):98-102.
    172. Prades J, Remue E, van Hoof E, Borras JM. Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health policy. 2015;119(4):464-74.
    173. Brannstrom F, Bjerregaard JK, Winbladh A, Nilbert M, Revhaug A, Wagenius G, et al. Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer. Acta oncologica. 2015;54(4):447-53.
    174. Chinai N, Bintcliffe F, Armstrong EM, Teape J, Jones BM, Hosie KB. Does every patient need to be discussed at a multidisciplinary team meeting? Clinical radiology. 2013;68(8):780-4.
    175. Ryan J, Faragher I. Not all patients need to be discussed in a colorectal cancer MDT meeting. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2014;16(7):520-6.
    176. European Partnership Action Against Cancer consensus g, Borras JM, Albreht T, Audisio R, Briers E, Casali P, et al. Policy statement on multidisciplinary cancer care. European journal of cancer. 2014;50(3):475-80.
    177. Nationella riktlinjer för bröst-, prostata-,tjocktarms- och ändtarmscancervård 2014. Socialstyrelsen ISBN 978-91-7555-162-3.
    178. Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nagino M. Review of hepatopancreatoduodenectomy for biliary cancer: an extended radical approach of Japanese origin. Journal of hepato-biliary-pancreatic sciences. 2014;21(8):550-5.
    179. Liu F, Li Y, Wei Y, Li B. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Digestive diseases and sciences. 2011;56(3):663-72.
    180. Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G, et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Archives of surgery. 2012;147(1):26-34.
    181. Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, et al. Surgery for hilar cholangiocarcinoma: the Leeds experience. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2008;34(7):787-94.
    182. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al. Extended resections for hilar cholangiocarcinoma. Annals of surgery. 1999;230(6):808-18; discussion 19.
    183. Ribero D, Amisano M, Lo Tesoriere R, Rosso S, Ferrero A, Capussotti L. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma. Annals of surgery. 2011;254(5):776-81; discussion 81-3.
    184. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World journal of surgery. 1990;14(4):535-43; discussion 44.
    185. Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, et al. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Annals of surgical oncology. 2012;19(5):1602-8.
    186. Abbas S, Sandroussi C. Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2013;15(7):492-503.
    187. Robles R, Figueras J, Turrion VS, Margarit C, Moya A, Varo E, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Annals of surgery. 2004;239(2):265-71.
    188. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation. 2000;69(8):1633-7.
    189. Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. Journal of hepatology. 2004;40(5):815-22.
    190. Seehofer D, Thelen A, Neumann UP, Veltzke-Schlieker W, Denecke T, Kamphues C, et al. Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2009;15(11):1499-507.
    191. Alessiani M, Tzakis A, Todo S, Demetris AJ, Fung JJ, Starzl TE. Assessment of five-year experience with abdominal organ cluster transplantation. Journal of the American College of Surgeons. 1995;180(1):1-9.
    192. Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Annals of surgery. 2005;242(3):451-8; discussion 8-61.
    193. Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Seminars in liver disease. 2004;24(2):201-7.
    194. Hassoun Z, Gores GJ, Rosen CB. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. Surgical oncology clinics of North America. 2002;11(4):909-21.
    195. Sudan D, DeRoover A, Chinnakotla S, Fox I, Shaw B, Jr., McCashland T, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2002;2(8):774-9.
    196. Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012;143(1):88-98 e3; quiz e14.
    197. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Annals of surgery. 2000;232(4):557-69.
    198. Blumgart LH, editor. Surgery of the liver and biliary tract. Edinburgh: Churchill Livingstone, 1988:721-52.
    199. Baer HU, Matthews JB, Schweizer WP, Gertsch P, Blumgart LH. Management of the Mirizzi syndrome and the surgical implications of cholecystcholedochal fistula. The British journal of surgery. 1990;77(7):743-5.
    200. Bower TC, Nagorney DM. Mirizzi syndrome. HPB surgery : a world journal of hepatic, pancreatic and biliary surgery. 1988;1(1):67-74; discussion 5-6.
    201. Prasad TL, Kumar A, Sikora SS, Saxena R, Kapoor VK. Mirizzi syndrome and gallbladder cancer. Journal of hepato-biliary-pancreatic surgery. 2006;13(4):323-6.
    202. Beltran MA, Csendes A, Cruces KS. The relationship of Mirizzi syndrome and cholecystoenteric fistula: validation of a modified classification. World journal of surgery. 2008;32(10):2237-43.
    203. Claudio A. Redaelli, MD, Markus W. Büchler, MD, Martin K. Schiiing, MD, Lukas Krähenbühl, MD, Charles Ruchti, MD, Leslie H. Blumgart, MD, and Hans U. Baer, MD, High coincidence of Mirizzi syndrome and gallbladder carcinoma Surgery 1996, Volume 121, Number 1.
    204. Costi R, Randone B, Violi V, Scatton O, Sarli L, Soubrane O, et al. Cholecystocolonic fistula: facts and myths. A review of the 231 published cases. Journal of hepato-biliary-pancreatic surgery. 2009;16(1):8-18.
    205. Lee SE, Jang JY, Lim CS, Kang MJ, Kim SW. Systematic review on the surgical treatment for T1 gallbladder cancer. World journal of gastroenterology : WJG. 2011;17(2):174-80.
    206. Hari DM, Howard JH, Leung AM, Chui CG, Sim MS, Bilchik AJ. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB : the official journal of the International Hepato Pancreato Biliary Association. 2013;15(1):40-8.
    207. Jensen EH, Abraham A, Habermann EB, Al-Refaie WB, Vickers SM, Virnig BA, et al. A critical analysis of the surgical management of early-stage gallbladder cancer in the United States. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2009;13(4):722-7.
    208. Goetze TO, Paolucci V. [Incidental T1b-T3 gallbladder carcinoma. Extended cholecystectomy as an underestimated prognostic factor-results of the German registry]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 2014;85(2):131-8.
    209. Downing SR, Cadogan KA, Ortega G, Oyetunji TA, Siram SM, Chang DC, et al. Early-stage gallbladder cancer in the Surveillance, Epidemiology, and End Results database: effect of extended surgical resection. Archives of surgery. 2011;146(6):734-8.
    210. Choi SB, Han HJ, Kim CY, Kim WB, Song TJ, Suh SO, et al. Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2010;14(4):668-78.
    211. de Aretxabala X, Roa I, Burgos L, Losada H, Roa JC, Mora J, et al. Gallbladder cancer: an analysis of a series of 139 patients with invasion restricted to the subserosal layer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2006;10(2):186-92.
    212. Fuks D, Regimbeau JM, Le Treut YP, Bachellier P, Raventos A, Pruvot FR, et al. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World journal of surgery. 2011;35(8):1887-97.
    213. Goetze TO, Paolucci V. Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry. Surgical endoscopy. 2010;24(9):2156-64.
    214. Goetze TO, Paolucci V. The prognostic impact of positive lymph nodes in stages T1 to T3 incidental gallbladder carcinoma: results of the German Registry. Surgical endoscopy. 2012;26(5):1382-9.
    215. Kai M, Chijiiwa K, Ohuchida J, Nagano M, Hiyoshi M, Kondo K. A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2007;11(8):1025-32.
    216. Kim DH, Kim SH, Choi GH, Kang CM, Kim KS, Choi JS, et al. Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer. World journal of surgery. 2013;37(11):2635-40.
    217. Yildirim E, Celen O, Gulben K, Berberoglu U. The surgical management of incidental gallbladder carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2005;31(1):45-52.
    218. Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, et al. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2010;14(10):1578-91.
    219. Shindoh J, de Aretxabala X, Aloia TA, Roa JC, Roa I, Zimmitti G, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Annals of surgery. 2015;261(4):733-9.
    220. Araida T, Higuchi R, Hamano M, Kodera Y, Takeshita N, Ota T, et al. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surgery today. 2009;39(9):770-9.
    221. Ishikawa T, Horimi T, Shima Y, Okabayashi T, Nishioka Y, Hamada M, et al. Evaluation of aggressive surgical treatment for advanced carcinoma of the gallbladder. Journal of hepato-biliary-pancreatic surgery. 2003;10(3):233-8.
    222. Liu GJ, Li XH, Chen YX, Sun HD, Zhao GM, Hu SY. Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis. World journal of gastroenterology : WJG. 2013;19(31):5150-8.
    223. Balachandran P, Agarwal S, Krishnani N, Pandey CM, Kumar A, Sikora SS, et al. Predictors of long-term survival in patients with gallbladder cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2006;10(6):848-54.
    224. Lim H, Seo DW, Park do H, Lee SS, Lee SK, Kim MH, et al. Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients. Journal of clinical gastroenterology. 2013;47(5):443-8.
    225. Ouchi K, Mikuni J, Kakugawa Y, Organizing Committee TtACotJSoBS. Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. Journal of hepato-biliary-pancreatic surgery. 2002;9(2):256-60.
    226. Endo I, Shimada H, Fujii Y, Sugita M, Masunari H, Miura Y, et al. Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion. Journal of hepato-biliary-pancreatic surgery. 2001;8(6):505-10.
    227. Choi SB, Han HJ, Kim WB, Song TJ, Suh SO, Choi SY. Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary? Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2013;398(8):1137-44.
    228. D'Angelica M, Dalal KM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Annals of surgical oncology. 2009;16(4):806-16.
    229. Kai K, Aishima S, Miyazaki K. Gallbladder cancer: Clinical and pathological approach. World journal of clinical cases. 2014;2(10):515-21.
    230. Yokomizo H, Yamane T, Hirata T, Hifumi M, Kawaguchi T, Fukuda S. Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome. Annals of surgical oncology. 2007;14(4):1366-73.
    231. Birnbaum DJ, Vigano L, Russolillo N, Langella S, Ferrero A, Capussotti L. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio. Annals of surgical oncology. 2015;22(3):811-8.
    232. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology. 2010;17(6):1471-4.
    233. Goetze TO, Paolucci V. Immediate re-resection of T1 incidental gallbladder carcinomas: a survival analysis of the German Registry. Surgical endoscopy. 2008;22(11):2462-5.
    234. You DD, Lee HG, Paik KY, Heo JS, Choi SH, Choi DW. What is an adequate extent of resection for T1 gallbladder cancers? Annals of surgery. 2008;247(5):835-8.
    235. Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, et al. Is para-aortic lymph node metastasis a contraindication for radical resection in biliary carcinoma? World journal of surgery. 2011;35(5):1085-93.
    236. Coburn NG, Cleary SP, Tan JC, Law CH. Surgery for gallbladder cancer: a population-based analysis. Journal of the American College of Surgeons. 2008;207(3):371-82.
    237. Jensen EH, Abraham A, Jarosek S, Habermann EB, Al-Refaie WB, Vickers SA, et al. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer. Surgery. 2009;146(4):706-11; discussion 11-3.
    238. Choi BG, Kim CY, Cho SH, Kim HJ, Koh YS, Kim JC, et al. Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma. Journal of the Korean Surgical Society. 2013;84(3):168-77.
    239. Araida T, Yoshikawa T, Azuma T, Ota T, Takasaki K, Hanyu F. Indications for pancreatoduodenectomy in patients undergoing lymphadenectomy for advanced gallbladder carcinoma. Journal of hepato-biliary-pancreatic surgery. 2004;11(1):45-9.
    240. Sasaki R, Itabashi H, Fujita T, Takeda Y, Hoshikawa K, Takahashi M, et al. Significance of extensive surgery including resection of the pancreas head for the treatment of gallbladder cancer--from the perspective of mode of lymph node involvement and surgical outcome. World journal of surgery. 2006;30(1):36-42.
    241. Horiguchi A, Miyakawa S, Ishihara S, Miyazaki M, Ohtsuka M, Shimizu H, et al. Gallbladder bed resection or hepatectomy of segments 4a and 5 for pT2 gallbladder carcinoma: analysis of Japanese registration cases by the study group for biliary surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Journal of hepato-biliary-pancreatic sciences. 2013;20(5):518-24.
    242. Araida T, Higuchi R, Hamano M, Kodera Y, Takeshita N, Ota T, et al. Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: results of a Japanese Society of Biliary Surgery survey--a multicenter study. Journal of hepato-biliary-pancreatic surgery. 2009;16(2):204-15.
    243. Kim WS, Choi DW, You DD, Ho CY, Heo JS, Choi SH. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2010;14(4):679-87.
    244. Meng H, Wang X, Fong Y, Wang ZH, Wang Y, Zhang ZT. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Japanese journal of clinical oncology. 2011;41(8):992-8.
    245. Birnbaum DJ, Vigano L, Ferrero A, Langella S, Russolillo N, Capussotti L. Locally advanced gallbladder cancer: which patients benefit from resection? European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014;40(8):1008-15.
    246. Kang MJ, Song Y, Jang JY, Han IW, Kim SW. Role of radical surgery in patients with stage IV gallbladder cancer. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2012;14(12):805-11.
    247. Kayahara M, Nagakawa T, Nakagawara H, Kitagawa H, Ohta T. Prognostic factors for gallbladder cancer in Japan. Annals of surgery. 2008;248(5):807-14.
    248. Wang RT, Xu XS, Liu J, Liu C. Gallbladder carcinoma: analysis of prognostic factors in 132 cases. Asian Pacific journal of cancer prevention : APJCP. 2012;13(6):2511-4.
    249. He XD, Li JJ, Liu W, Qu Q, Hong T, Xu XQ, et al. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer. World journal of gastroenterology : WJG. 2015;21(15):4620-6.
    250. Xiao WD, Peng CH, Zhou GW, Wu WD, Shen BY, Yan JQ, et al. Surgical treatment for Nevin stage IV and V gallbladder carcinoma: report of 70 cases. Hepatobiliary & pancreatic diseases international : HBPD INT. 2005;4(4):589-92.
    251. Higuchi R, Ota T, Araida T, Kajiyama H, Yazawa T, Furukawa T, et al. Surgical approaches to advanced gallbladder cancer : a 40-year single-institution study of prognostic factors and resectability. Annals of surgical oncology. 2014;21(13):4308-16.
    252. Goetze TO, Paolucci V. Prognosis of incidental gallbladder carcinoma is not influenced by the primary access technique: analysis of 837 incidental gallbladder carcinomas in the German Registry. Surgical endoscopy. 2013;27(8):2821-8.
    253. Itano O, Oshima G, Minagawa T, Shinoda M, Kitago M, Abe Y, et al. Novel strategy for laparoscopic treatment of pT2 gallbladder carcinoma. Surgical endoscopy. 2015.
    254. Zhang WJ, Xu GF, Tian ZQ, Wu GZ, Wang H, Guan WX. Surgical approach does not influence the outcome of incidental gallbladder carcinoma. International journal of clinical and experimental medicine. 2015;8(1):869-75.
    255. Butte JM, Gonen M, Allen PJ, D'Angelica MI, Kingham TP, Fong Y, et al. The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2011;13(7):463-72.
    256. Agarwal AK, Kalayarasan R, Javed A, Gupta N, Nag HH. The role of staging laparoscopy in primary gall bladder cancer--an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer. Annals of surgery. 2013;258(2):318-23.
    257. Noji T, Tsuchikawa T, Mizota T, Okamura K, Nakamura T, Tamoto E, et al. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases. World journal of surgical oncology. 2015;13:82.
    258. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Annals of surgical oncology. 2006;13(10):1271-80.
    259. Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Annals of surgery. 2006;244(2):240-7.
    260. Tarazov PG, Granov DA, Sergeev VI, Polikarpov AA, Polysalov VN, Rozengauz EV. Preoperative portal vein embolization for liver malignancies. Hepato-gastroenterology. 2006;53(70):566-70.
    261. Yi B, Xu AM, Lai EC, Qu ZQ, Cheng QB, Liu C, et al. Preoperative portal vein embolization for hilar cholangiocarcinoma--a comparative study. Hepato-gastroenterology. 2010;57(104):1341-6.
    262. Sofue K, Arai Y, Shimada K, Takeuchi Y, Kobayashi T, Satake M, et al. Right portal vein embolization with absolute ethanol in major hepatic resection for hepatobiliary malignancy. The British journal of surgery. 2014;101(9):1122-8.
    263. Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness--study in 26 patients. Radiology. 2003;227(1):251-60.
    264. Tabata M, Kawarada Y, Yokoi H, Higashiguchi T, Isaji S. Surgical treatment for hilar cholangiocarcinoma. Journal of hepato-biliary-pancreatic surgery. 2000;7(2):148-54.
    265. Iida H, Aihara T, Ikuta S, Yoshie H, Yamanaka N. Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation. World journal of gastroenterology : WJG. 2012;18(19):2371-6.
    266. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Annals of surgery. 2006;243(3):364-72.
    267. Tsuda M, Kurihara N, Saito H, Yamaki T, Shimamura H, Narushima Y, et al. Ipsilateral percutaneous transhepatic portal vein embolization with gelatin sponge particles and coils in preparation for extended right hepatectomy for hilar cholangiocarcinoma. Journal of vascular and interventional radiology : JVIR. 2006;17(6):989-94.
    268. Guiu B, Bize P, Gunthern D, Demartines N, Halkic N, Denys A. Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils. Cardiovascular and interventional radiology. 2013;36(5):1306-12.
    269. van Lienden KP, van den Esschert JW, de Graaf W, Bipat S, Lameris JS, van Gulik TM, et al. Portal vein embolization before liver resection: a systematic review. Cardiovascular and interventional radiology. 2013;36(1):25-34.
    270. Spelt L, Ansari D, Sturesson C, Tingstedt B, Andersson R. Fast-track programmes for hepatopancreatic resections: where do we stand? HPB : the official journal of the International Hepato Pancreato Biliary Association. 2011;13(12):833-8.
    271. Jones C, Kelliher L, Dickinson M, Riga A, Worthington T, Scott MJ, et al. Randomized clinical trial on enhanced recovery versus standard care following open liver resection. The British journal of surgery. 2013;100(8):1015-24.
    272. Schultz NA, Larsen PN, Klarskov B, Plum LM, Frederiksen HJ, Christensen BM, et al. Evaluation of a fast-track programme for patients undergoing liver resection. The British journal of surgery. 2013;100(1):138-43.
    273. Coolsen MM, Wong-Lun-Hing EM, van Dam RM, van der Wilt AA, Slim K, Lassen K, et al. A systematic review of outcomes in patients undergoing liver surgery in an enhanced recovery after surgery pathways. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2013;15(4):245-51.
    274. Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98(8):1689-700.
    275. Williams TM, Majithia L, Wang SJ, Thomas CR, Jr. Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer. Seminars in radiation oncology. 2014;24(2):94-104.
    276. https://www.clinicaltrials.gov/ct2/show/NCT01073839?term=cholangiocarcinoma+adjuvant&rank=3.
    277. Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, et al. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. Annals of surgical oncology. 2015.
    278. Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012;30(16):1934-40.
    279. Aitken KL, Hawkins MA. The role of radiotherapy and chemoradiation in the management of primary liver tumours. Clinical oncology. 2014;26(9):569-80.
    280. Sur MD, In H, Sharpe SM, Baker MS, Weichselbaum RR, Talamonti MS, et al. Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma. Annals of surgical oncology. 2015;22(7):2209-17.
    281. Ramirez-Merino N, Aix SP, Cortes-Funes H. Chemotherapy for cholangiocarcinoma: An update. World journal of gastrointestinal oncology. 2013;5(7):171-6.
    282. Vogel A, Wege H, Caca K, Nashan B, Neumann U. The diagnosis and treatment of cholangiocarcinoma. Deutsches Arzteblatt international. 2014;111(44):748-54.
    283. Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary surgery and nutrition. 2014;3(1):18-34.
    284. Harder J, Riecken B, Kummer O, Lohrmann C, Otto F, Usadel H, et al. Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer. British journal of cancer. 2006;95(7):848-52.
    285. Singhal D, van Gulik TM, Gouma DJ. Palliative management of hilar cholangiocarcinoma. Surgical oncology. 2005;14(2):59-74.
    286. Glimelius B, Hoffman K, Sjoden PO, Jacobsson G, Sellstrom H, Enander LK, et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 1996;7(6):593-600.
    287. Gallardo JO, Rubio B, Fodor M, Orlandi L, Yanez M, Gamargo C, et al. A phase II study of gemcitabine in gallbladder carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2001;12(10):1403-6.
    288. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. The New England journal of medicine. 2010;362(14):1273-81.
    289. Penz M, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Lenauer A, et al. Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2001;12(2):183-6.
    290. Andre T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D, et al. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2004;15(9):1339-43.
    291. Pracht M, Le Roux G, Sulpice L, Mesbah H, Manfredi S, Audrain O, et al. Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years. Chemotherapy. 2012;58(2):134-41.
    292. Iqbal S, Rankin C, Lenz HJ, Gold PJ, Ahmad SA, El-Khoueiry AB, et al. A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. Cancer chemotherapy and pharmacology. 2011;68(6):1595-602.
    293. Fiteni F, Nguyen T, Vernerey D, Paillard MJ, Kim S, Demarchi M, et al. Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review. Cancer medicine. 2014;3(6):1502-11.
    294. Yang R, Wang B, Chen YJ, Li HB, Hu JB, Zou SQ. Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a meta-analysis. Anti-cancer drugs. 2013;24(8):871-7.
    295. Lamarca A, Hubner RA, David Ryder W, Valle JW. Second-line chemotherapy in advanced biliary cancer: a systematic review. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014;25(12):2328-38.
    296. Howell M, Valle JW. The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma. Best practice & research Clinical gastroenterology. 2015;29(2):333-43.
    297. Stein DE, Heron DE, Rosato EL, Anne PR, Topham AK. Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy. American journal of clinical oncology. 2005;28(1):21-3.
    298. Tanguturi SK, Wo JY, Zhu AX, Dawson LA, Hong TS. Radiation therapy for liver tumors: ready for inclusion in guidelines? The oncologist. 2014;19(8):868-79.
    299. Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, et al. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients. Cancer journal. 2006;12(2):113-22.
    300. Polistina FA, Guglielmi R, Baiocchi C, Francescon P, Scalchi P, Febbraro A, et al. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2011;99(2):120-3.
    301. Hoffmann RT, Paprottka PM, Schon A, Bamberg F, Haug A, Durr EM, et al. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovascular and interventional radiology. 2012;35(1):105-16.
    302. Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, et al. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer. 2008;113(8):2119-28.
    303. Mouli S, Memon K, Baker T, Benson AB, 3rd, Mulcahy MF, Gupta R, et al. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. Journal of vascular and interventional radiology : JVIR. 2013;24(8):1227-34.
    304. Turkmen C, Ucar A, Poyanli A, Vatankulu B, Ozkan G, Basaran M, et al. Initial outcome after selective intraarterial radionuclide therapy with yttrium-90 microspheres as salvage therapy for unresectable metastatic liver disease. Cancer biotherapy & radiopharmaceuticals. 2013;28(7):534-40.
    305. Sulpice L, Rayar M, Boucher E, Pracht M, Meunier B, Boudjema K. Treatment of recurrent intrahepatic cholangiocarcinoma. The British journal of surgery. 2012;99(12):1711-7.
    306. Kim JH, Yoon HK, Sung KB, Ko GY, Gwon DI, Shin JH, et al. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes. Cancer. 2008;113(7):1614-22.
    307. Vogl TJ, Naguib NN, Nour-Eldin NE, Bechstein WO, Zeuzem S, Trojan J, et al. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success. International journal of cancer Journal international du cancer. 2012;131(3):733-40.
    308. Kuhlmann JB, Euringer W, Spangenberg HC, Breidert M, Blum HE, Harder J, et al. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy. European journal of gastroenterology & hepatology. 2012;24(4):437-43.
    309. Boehm LM, Jayakrishnan TT, Miura JT, Zacharias AJ, Johnston FM, Turaga KK, et al. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma. Journal of surgical oncology. 2015;111(2):213-20.
    310. Lindström D. The impact of tobacco use on postoperative complications [avhandling]. Stockholm: Karolinska institutet; 2008 
    311. Wahlin S, Tonnesen H. [Time for "alcohol-free operations". Two standard drinks a day doubles the risk of postoperative complications]. Lakartidningen. 2014;111(44-45):1966-9.
    312. Schisler RE, Groninger H, Rosielle DA. Counseling patients on side effects and driving when starting opioids #248. Journal of palliative medicine. 2012;15(4):484-5.
    313. Coleman EA, Boult C, American Geriatrics Society Health Care Systems C. Improving the quality of transitional care for persons with complex care needs. Journal of the American Geriatrics Society. 2003;51(4):556-7.
    314. Lithner, M. and T. Zilling, Does preoperative information increase the wellbeing of the patient after surgery? (in Swedish) Vår d i Norden 1998; 18:31-33,39,1998.
    315. Burney M, Purden M, McVey L. Patient satisfaction and nurses' perceptions of quality in an inpatient cardiology population. Journal of nursing care quality. 2002;16(4):56-67; quiz 8-9.
    316. Jones KR, Burney RE, Christy B. Patient expectations for surgery: are they being met? The Joint Commission journal on quality improvement. 2000;26(6):349-60.
    317. Keulers BJ, Scheltinga MR, Houterman S, Van Der Wilt GJ, Spauwen PH. Surgeons underestimate their patients' desire for preoperative information. World journal of surgery. 2008;32(6):964-70.
    318. Lithner M, Zilling T. Pre- and postoperative information needs. Patient education and counseling. 2000;40(1):29-37.
    319. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute. 1993;85(5):365-76.
    320. Friend E, Yadegarfar G, Byrne C, Johnson CD, Sezer O, Pucciarelli S, et al. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21. British journal of cancer. 2011;104(4):587-92.
    321. Blazeby JM, Currie E, Zee BC, Chie WC, Poon RT, Garden OJ, et al. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. European journal of cancer. 2004;40(16):2439-44.
    322. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. Journal of palliative care. 1991;7(2):6-9.
    323. Grundmann S, Stander S. Chronic pruritus: clinics and treatment. Annals of dermatology. 2011;23(1):1-11.
    324. Muir CA. Acute ascending cholangitis. Clinical journal of oncology nursing. 2004;8(2):157-60.
    325. Cavazzoni E, Bugiantella W, Graziosi L, Franceschini MS, Donini A. Malignant ascites: pathophysiology and treatment. International journal of clinical oncology. 2013;18(1):1-9.
    326. Robson PC, Heffernan N, Gonen M, Thornton R, Brody LA, Holmes R, et al. Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction. Annals of surgical oncology. 2010;17(9):2303-11.
    327. Strang p., Beck-Friis B., (red) Palliativ medicin och vård. 4 uppl. Stockholm : Liber . 2012.
    328. Fan SY, Eiser C, Ho MC. Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2010;8(7):559-64 e1-10.
    329. Somjaivong B, Thanasilp S, Preechawong S, Sloan R. The influence of symptoms, social support, uncertainty, and coping on health-related quality of life among cholangiocarcinoma patients in northeast Thailand. Cancer nursing. 2011;34(6):434-42.
    330. Benkel I, Wijk H, Molander U. Loved ones obtain various information about the progression of the patient's cancer disease which is important for their understanding and preparation. The American journal of hospice & palliative care. 2012;29(1):64-9.
    331. Gustafsson, B. (2004). Bekräftande omvårdnad: SAUK-modellen för vård och omsorg. Lund: Studentlitteratur.
    332. Dambrauskas Z, Paskauskas S, Lizdenis P, Uktveris R, Pranculis A, Kaupas RS, et al. Percutaneous transhepatic biliary stenting: the first experience and results of the Hospital of Kaunas University of Medicine. Medicina. 2008;44(12):969-76.
    333. Patienters upplevelse av att leva med Perkutant Transhepatiskt Cholangiografi (PTC)-dränage och deras upplevelser av kontakten med sjukhusvården; C-uppsats av G. Olsson och C. Wallin, Uppsala universitet.
    334. NANDA-international, Omvårdnadsdiagnoser – definition och klassifikation 2012-2014, Studentlitteratur 2013, översättning Jan Florin.
    335. Goldhill DR, McNarry AF, Hadjianastassiou VG, Tekkis PP. The longer patients are in hospital before Intensive Care admission the higher their mortality. Intensive care medicine. 2004;30(10):1908-13.
    336. Wrighton LJ, O'Bosky KR, Namm JP, Senthil M. Postoperative management after hepatic resection. Journal of gastrointestinal oncology. 2012;3(1):41-7.
    337. Greer JA, Pirl WF, Jackson VA, Muzikansky A, Lennes IT, Heist RS, et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012;30(4):394-400.